Jhpiego

November 9-13, 2025 | Metro Toronto Convention Center, Canada

Join Jhpiego at the 2025 American Society of Tropical Medicine and Hygiene Annual Meeting

Attend Jhpiego’s side-event, oral presentations, and poster sessions to learn about our expertise and innovative solutions aimed at preventing and treating malaria.

Access to quality malaria prevention and treatment services is essential

At Jhpiego, we believe that if we support National Malaria Programs to achieve critical components of effective malaria programming and implementation, we will help countries overcome barriers to access, quality and uptake of malaria services while strengthening the efficiency of health systems and women and their families will benefit from the evidence-based interventions that are recommended by the World Health Organization. Our key approaches include:

Prevention

Where there is heavy rain and malaria transmission is seasonal, we advocate for and support the intermittent administration of full treatment courses of an antimalaria medicine by implementing seasonal malaria chemoprevention campaigns. These campaigns are crucial during the malaria season to prevent malaria illness and deaths in children under five years, protecting them throughout the period of greatest malaria risk.
We support the prevention of malaria in pregnancy through antenatal care services by providing insecticide-treated nets, including counseling on their use during first antenatal visit, and by providing intermittent preventive treatment of antimalarial medication during pregnancy to reduce the burden of malaria infection among pregnant women. We implement this support in areas with moderate to high levels of malaria transmission through collaboration with national malaria programs and reproductive and maternal health programs.
We educate communities about the importance of the malaria vaccine and collaborate with national malaria and immunization programs to support the decision-making, planning, implementation, and monitoring that goes with introducing and scaling the malaria vaccine alongside other malaria prevention interventions in children.

Diagnosis and Treatment

We support the strengthening of systems for improving malaria case management by building the capacity of health providers at the community and facility levels and providing them with tools and quality improvement support to promptly test for malaria and appropriately categorize and treat malaria cases.

Jhpiego Attendees

Gladys Tetteh, Senior Technical Director for Malaria

Rima Shretta, Project Director, STOP-AMDR Project

Naoko Doi, Team Lead for Market Access

Annick Sidibe, Senior Technical Advisor, Global Health Security

FEATURED SESSIONS

Join us at the sessions below to learn from our experts in global health about diverse topics, from practical implementation approaches to innovative solutions to prevent and treat infectious diseases to leveraging digital health to improving awareness and behavior change.

Assessing policy decisions and implementation impact of the Pneumococcal Conjugate Vaccine Schedule Change in Burkina Faso

Wednesday, November 12, 2025 | 5:15 PM - 7:00 PM | Scientific Session 164 | Respiratory Infections II

Using Mobile Platforms to Drive Malaria Vaccine Awareness and Behavior Change in the Integrated Health Services (IHS) project areas in Burkina Faso

Wednesday, November 12, 2025 | 9:15 AM - 11:00 AM | Scientific Session 117

SIDE EVENT

Processes and challenges for operationalizing artemisinin-based combination therapy (ACT) diversification policies

This side-event will provide a forum to discuss approaches to address potential operational challenges in implementing multiple first-line treatments (MFTs) and highlight how the Unitaid Scaling the Optimal Use of Multiple ACTs to Prevent Antimalarial Drug Resistance (STOP-AMDR) project will support countries to resolve them.

Tuesday, November 11, 2025 | 12:00 PM – 2:30 PM | Convention Center 712

POSTER PRESENTATIONS

Six-Month Review of Malaria Vaccine Introduction in Burkina Faso: Lessons Learned and Strategic Directions

Poster Session A | Monday, November 10, 2025 | 12:30 PM – 2:15 PM

Acceptability, Knowledge, Attitudes and Practices on Malaria Vaccination Among Caregivers in Liberia, 2024

Poster Session B | Tuesday, November 11, 2025 | 12:00 PM – 1:45 PM

Integrated malaria prevention and treatment during Seasonal Malaria Chemoprevention (SMC) cycles: Lessons from Burkina Faso’s 2024 Campaign

Poster Session B | Tuesday, November 11, 2025 | 12:00 PM – 1:45 PM

Evaluation of the impact of insecurity and the COVID-19 pandemic on meningitis surveillance in Burkina Faso, 2015–2021.

Poster Session B | Tuesday, November 11, 2025 | 12:00 PM – 1:45 PM

Rethinking Seasonal Malaria Chemoprevention (SMC: Impact of Strategy Shifts on Childhood Malaria in North and Far North regions of Cameroon